You are here:

New Product Development List copy

Inquiry Form

Select One or Multiple Products for Inquiry

Product Indication Segment/Class COA GMP DML DMF
BENDAMUSTINE HCL Chronic lymphocytic
leukemia (CLL)
Alkylating agent
TROPICAMIDE Pupil dilation for eye exams Anticholinergic
TENOFOVIR
ALAFENAMIDE FUMARATE
HIV infection, hepatitis B
virus (HBV) infection
Antiretroviral, Antiviral
LEVOSIM ENDAN Acute heart failure,
decompensated heart failure
Calcium sensitizer
BRINZOLAMIDE Glaucoma, ocular
hypertension
Carbonic anhydrase
inhibitor
APIXABAN Venous thromboembolism
prevention
Cardiology
IVABRADINE HCL Heart failure. angina Cardiology
MILRINONE BASE/HCL Heart failure Cardiology
MILRINONE LACTATE Heart failure Cardiology
PEMAFIBRATE Dyslipidemia Cardiology
RIVAROXABAN Venous thromboembolism
prevention
Cardiology
SACUBITRIL +VALSARTAN Heart failure Cardiology
TICAGRFLOR BASE/HCL Acute coronary syndrome
prevention
Cardiology
VERICUGAT Heart failure, chronic
kidney disease
Cardiology,
Nephrology
RIBOCICLIB Breast cancer, hormone
receptor-positive, HER2- negative
CDK4/6 Inhibitor
TAPINAROF Plaque psoriasis Dermatology
ALOGLIPTIN BENZOATE Type 2 diabetes mellitus Endocrinology
CANAGLIFLOZIN Type 2 diabetes mellitus Endocrinology
DAPAGLIFLOZIN PROPANE Type 2 diabetes mellitus Endocrinology
DULAGLUTIDE Type 2 diabetes mellitus Endocrinology
EMPAGLIFLOZIN Type 2 diabetes mellitus Endocrinology
ERTUGLIFLOZIN L— PYROGLU Type 2 diabetes mellitus Endocrinology
IPRAGLIFLOZIN L-PROLINE Type 2 diabetes mellitus Endocrinology
LINAGLIPTIN Type 2 diabetes mellitus Endocrinology
OMARIGL1PTIN Type 2 diabetes mellitus Endocrinology
SAXAGLIPTIN HCL/HYDRATE Type 2 diabetes mellitus Endocrinology
SEMAGLUTIDE Type 2 diabetes mellitus Endocrinology
SITAGLIPTIN PHOSPHATE Type 2 diabetes mellitus Endocrinology
SOTAGLIFLOZIN Type 1 diabetes mellitus Endocrinology
TENELIGLIPTIN Type 2 diabetes mellitus Endocrinology
TRELAGLIPTIN SUCCINATE Type 2 diabetes mellitus Endocrinology
SPARSENTAN Focal segmental
glomerulosclerosis (FSGS),
Endothelin Receptor
Antagonist and
Angiotensin II Receptor Blocker
OBETICHOLIC ACID Primary biliary cholangitis Gastroenterology
TEDUGLUTIDE Short bowel syndrome Gastroenterology
VONOPRAZAN FUMARATE Gastroesophageal reflux
disease
Gastroenterology
LINZAGOLIX Endometriosis, Uterine
Fibroids
GnRH receptor
antagonist
ELAGOLIX SODIUMELAGOLIX SODIUM Endometriosis, uterine
fibroids
Gynecology
RUXOLITINIB Myelofibrosis, polycythemia
vera
Hematology
ROXADUSTAT Anemia associated with
chronic kidney disease (CKD)
HIF-ProIyI Hydroxylase
Inhibitor
PITAVASTATIN CALCIUM Hypercholesterolemia,
prevention of cardiovascular events
HMG-CoA reductase
inhibitor (Stating)
BRINCIDOFOVIR Antiviral therapy for CMV
infections
Infectious diseases
MOLNUPIRAVIR Oral treatment for COVID-19 Infectious diseases
RITLECITINIB TOSYLATE Rheumatoid arthritis, atopic
dermatitis
JAK Inhibitor
PEFICITINIB
HYDROBROMIDE
Rheumatoid arthritis Janus Kinase (JAK)
Inhibitor
LIFITEGRAST Dry eye disease Lymphocyte function-
associated antigen 1
(LFA 1) antagonist
IMEGLIMIN HCL Type 2 diabetes mellitus Mitochondrial
bioenergetics modulator
VAVACAMTEN Hypertrophic
cardiomyopathy
Myosin inhibitor
DAPRODUSTAT Anemia associated with
chronic kidney disease
Nephrology
FINERENONE Chronic kidney disease, heart
failure
Nephrology,
Cardiology
*EZOLINETANT Vasomotor symptoms
associated with menopause,
Neurokinin 3 (NK3)
receptor antagonist
CLOBAZAM Epilepsy Neurology
MIROGABALIN BESYLATE Fibromyalgia Neurology
DACLATASVIR Chronic hepatitis C virus
(HCV) infection
WS5Ainibitoc
VELPATASVIR Chronic hepatitis C virus
(HCV) infection
NSSA inhibitor
LEDIPASVIR COPOVIDONE Chronic hepatitis C virus
(HCV) infection
NSW A inhibitor
SOTORASIB Non-small cell lung cancer Oncology
SUNITINIB Renal cell carcinoma,
gastrointestinal stromal
tumor
Oncology
TRAMETINIB Melanoma, non-small cell
lung cancer
Oncology
TUCATINIIB Solid tumors with FGFR
genetic alterations
Oncology
VENCLEXTA Chronic lymphocytic
leukemia
Oncology
GEFAPIXANT CITRATE Chronic cough P2X3 Receptor
Antagonist
LATANOPROST Glaucoma, ocular
hypertension
Prostaglandin analog
FLIBANSERIN Hypoactive sexual desire
disorder
Psychiatry
FLUPENTIXOL
DECANOATE
Schizophrenia Psychiatry
FLUPENTIXOL HCL Schizophrenia Psychiatry
FLUPHENAZINE
DECANOATE
Schizophrenia Psychiatry
NITRAZEPAM Anxiety disorders, insomnia Psychiatry
ZOLPIDEM TARTRATE Insomnia Psychiatry
ZOPICLONE Insomnia Psychiatry
BARICITINIB Rheumatoid arthritis Rheumatoid arthritis
DEUCRAVACITINIB Rheumatoid arthritis Rheumatology
FILGOTINIB
BASE/MALEATE
Rheumatoid arthritis, Crohn’s
disease
Rheumatology
TOFACITINIB CITRATE Rheumatoid arthritis Rheumatology
UPADACITINIB HEMI. Rheumatoid arthritis,
psoriatic arthritis
Rheumatology
BEXAGLIFLOZIN Type 2 diabetes mellitus Rheumatology
REMOGLVLOZN
ETABONATE
Type 2 diabetes mellitus Sodium-glucose co-
transporter 2 (SGLT2) Inhibitor
LUSEOGLIF LOZIN Type 2 diabetes mellitus Sodium-glucose co-
transporter 2 (SGLT2)
Inhibitor
RIOCIGUAT Pulmonary arterial
hypertension (PAH)
Sodium-glucose co-
transporter 2 (SGLT2) Inhibitor
POSACONAZOLE Fungal infections Triazole antifungal
DOTINURAD Hyperuricemia associated
with gout
Uricosuric Agent
VI8EGRON Overactive bladder
syndrome
Urology
TOPIROXOSTAT Hyperuricemia associated
with gout
Xanthine oxidase
inhibitor
SOFOSBUVIR Chronic Hepatitis C virus (HCV) infection Nucleotide analog NSW B polymerase
inhibitor
ABEMACICLIB Breast cancer Oncology
ACALABRUTINIB Mantle cell lymphoma Oncology
AFATINIB Non small cell lung cancer Oncology
ALPELISIB Breast cancer Oncology
BINIMETINIB Melanoma Oncology
BOSUTINIB Chronic myelogenous
leukemia
Oncology
BRIGATINIB Non-small cell lung cancer Oncology
CABOZANTINIB Renal cell carcinoma,
hepatocellular carcinoma
Oncology
CAPMATINIB Non small cell lung cancer Oncology
DACOMITINIB Non small cell lung cancer Oncology
DASATINIB Chronic myelogenous
leukemia
Oncology
FRDAFITINIB Urothelial carcinoma Oncology
IBRUTINIB Mantle cell lymphoma,
chronic lymphocytic leukemia
Oncology
LAPATINIB Breast cancer Oncology
LAROTRECTINIB Solid tumors with NTRK
gene fusion
Oncology
LENVATINIB Thyroid cancer, liver cancer Oncology
LORATINIB Non small cell lung cancer Oncology
NERATINIB Breast cancer Oncology
NIRAPARIB Ovarian, fallopian tube, or
primary peritoneal cancer
Oncology
OLAPARIB Ovarian, breast, prostate
cancer
Oncology
OSIMERTINIB Non-small cell lung cancer Oncology
PALBOCICLIB Breast cancer Oncology
PAZOPANIB Kidney cancer, soft tissue
sarcoma
Oncology
PEMIGATINIB Cholangiocarcinoma Oncology
PONATINIB Chronic myelogenous
leukemia
Oncology
PRALSETINIB Solid tumors with MET
alterations
Oncology
REGORAFENIB Colorectal, liver,
gastrointestinal stromal cancer
Oncology
RELUGOLIX Prostate cancer Oncology
REPOTRECTINIB Solid tumors with ROS1 or
NTRK gene fusion
Oncology
RUXAPARIB Ovarian, fallopian tube, or
primary peritoneal cancer
Oncology
SARACATINIB Solid tumors with MET gene amplification Oncology
SORA*ENIB Kidney cancer, liver cancer Oncology